IDEAS home Printed from https://ideas.repec.org/f/c/pba359.html
   My authors  Follow this author

David Bardey

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Blog mentions

As found by EconAcademics.org, the blog aggregator for Economics research:
  1. David Bardey & Philippe De Donder & Cesar Mantilla, 2017. "How is the Trade-off between Adverse Selection and Discrimination Risk Affected by Genetic Testing? Theory and Experiment," CESifo Working Paper Series 6402, CESifo.

    Mentioned in:

    1. Chris Sampson’s journal round-up for 28th October 2019
      by Chris Sampson in The Academic Health Economists' Blog on 2019-10-28 12:00:05
  2. Yaping Wu & David Bardey & Yijuan Chen & Sanxi Li, 2021. "Health care insurance policies When the provider and patient may collude," Health Economics, John Wiley & Sons, Ltd., vol. 30(3), pages 525-543, March.

    Mentioned in:

    1. Chris Sampson’s journal round-up for 8th March 2021
      by Chris Sampson in The Academic Health Economists' Blog on 2021-03-08 12:00:01
  3. David Bardey & Fernando Jaramillo, 2011. "Unemployment insurance and informality in developing countries," Documentos de Trabajo 9015, Universidad del Rosario.

    Mentioned in:

    1. Unemployment insurance in developing economies?
      by Economic Logician in Economic Logic on 2011-11-01 19:49:00

RePEc Biblio mentions

As found on the RePEc Biblio, the curated bibliography of Economics:
  1. Bardey, David & Fernandez, Manuel & Gravel, Alexis, 2021. "Coronavirus and Social Distancing: Do Non-Pharmaceutical-Interventions Work (at least) in the Short Run?," TSE Working Papers 21-1189, Toulouse School of Economics (TSE).

    Mentioned in:

    1. > Economics of Welfare > Health Economics > Economics of Pandemics > Specific pandemics > Covid-19 > Health > Distancing and Lockdown > Measurement and effect on mobility

Working papers

  1. Yaping Wu & David Bardey & Yijuan Chen & Sanxi Li, 2021. "Health care insurance payment policy when the provider and patient May Collude," Post-Print hal-03722547, HAL.

    Cited by:

    1. Elias Carroni & Giuseppe Pignataro & Luigi Siciliani, 2023. "Persuasion in Physician Agency," Discussion Papers 23/01, Department of Economics, University of York.

  2. David Bardey & Arturo Harker & Daniela Zuluaga, 2021. "Price cap regulation in the Colombian pharmaceutical market: An impact evaluation," Documentos CEDE 19117, Universidad de los Andes, Facultad de Economía, CEDE.

    Cited by:

    1. Andia, Tatiana & Mantilla, César & Morales, Álvaro & Ortiz, Santiago & Rodríguez-Lesmes, Paul, 2022. "Does price-cap regulation work for increasing access to contraceptives? Aggregate- and pharmacy-level evidence from Colombia," Social Science & Medicine, Elsevier, vol. 311(C).

  3. David Bardey & Manuel Fernández & Alexis Gravel, 2021. "Coronavirus and Social Distancing: Do Non-Pharmaceutical-Interventions Work (at least) in the Short Run?," Documentos CEDE 18729, Universidad de los Andes, Facultad de Economía, CEDE.

    Cited by:

    1. Andres Rodriguez-Pose & Miquel Vidal-Bover, 2023. "Decentralisation, Unfunded Mandates, and the Regional Response to the COVID-19 Pandemic," International Center for Public Policy Working Paper Series, at AYSPS, GSU paper2307, International Center for Public Policy, Andrew Young School of Policy Studies, Georgia State University.

  4. Pouyet, Jérôme & Martimort, David & Gromb, Denis & Bardey, David, 2019. "Controlling Sellers Who Provide Advice: Regulation and Competition," CEPR Discussion Papers 13543, C.E.P.R. Discussion Papers.

    Cited by:

    1. Chen, Yongmin & Li, Jianpei & Zhang, Jin, 2017. "Efficient Liability in Expert Markets," MPRA Paper 104090, University Library of Munich, Germany, revised 06 Nov 2020.
    2. Marc Bourreau & Germain Gaudin, 2018. "Streaming Platform and Strategic Recommendation Bias," CESifo Working Paper Series 7390, CESifo.
    3. Bertrand Crettez & Régis Deloche & Marie‐Hélène Jeanneret‐Crettez, 2020. "A demand‐induced overtreatment model with heterogeneous experts," Journal of Public Economic Theory, Association for Public Economic Theory, vol. 22(5), pages 1713-1733, September.

  5. Bardey, David & De Donder, Philippe, 2019. "A Welfare Analysis of Genetic Testing in Health Insurance Markets with Adverse Selection and Prevention," TSE Working Papers 19-1035, Toulouse School of Economics (TSE), revised 22 Jan 2024.

    Cited by:

    1. Bardey, David & De Donder, Philippe & Mantilla, César, 2019. "How is the trade-off between adverse selection and discrimination risk affected by genetic testing? Theory and experiment," Journal of Health Economics, Elsevier, vol. 68(C).
    2. Posey, Lisa L. & Thistle, Paul D., 2021. "Genetic testing and genetic discrimination: Public policy when insurance becomes “too expensive”," Journal of Health Economics, Elsevier, vol. 77(C).

  6. David Bardey & Samuel Kembou Nzale & Bruno Ventelou, 2018. "Physicians’ Incentives to Adopt Personalized Medicine: Experimental Evidence," AMSE Working Papers 1823, Aix-Marseille School of Economics, France.

    Cited by:

    1. Michel Mougeot & Florence Naegelen, 2022. "Incentives to implement personalized medicine under second‐best pricing," Health Economics, John Wiley & Sons, Ltd., vol. 31(11), pages 2411-2424, November.
    2. Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2022. "Competing with precision: incentives for developing predictive biomarker tests," NIPE Working Papers 3/2022, NIPE - Universidade do Minho.
    3. Bardey, David & De Donder , Philippe & Zaporozhets , Vera, 2024. "Economic Incentives to Develop and to Use Diagnostic Tests a Literature Review," Documentos CEDE 21024, Universidad de los Andes, Facultad de Economía, CEDE.
    4. Finocchiaro Castro, Massimo & Guccio, Calogero & Romeo, Domenica, 2022. "A systematic literature review of 10 years of behavioral research on health services," EconStor Preprints 266248, ZBW - Leibniz Information Centre for Economics.
    5. De Donder, Philippe & Bardey, David & Zaporozhets, Vera, 2024. "Economic Incentives to Develop and to Use Diagnostic Tests - A Literature Review," TSE Working Papers 24-1507, Toulouse School of Economics (TSE).

  7. David Bardey & Philippe De Donder & Cesar Mantilla, 2017. "How is the Trade-off between Adverse Selection and Discrimination Risk Affected by Genetic Testing? Theory and Experiment," CESifo Working Paper Series 6402, CESifo.

    Cited by:

    1. Bardey, David & De Donder, Philippe, 2019. "A Welfare Analysis of Genetic Testing in Health Insurance Markets with Adverse Selection and Prevention," TSE Working Papers 19-1035, Toulouse School of Economics (TSE), revised 22 Jan 2024.
    2. Martin Eling & Ruo Jia & Jieyu Lin & Casey Rothschild, 2022. "Technology heterogeneity and market structure," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 89(2), pages 427-448, June.
    3. Karlsson Linnér, Richard & Koellinger, Philipp D., 2022. "Genetic risk scores in life insurance underwriting," Journal of Health Economics, Elsevier, vol. 81(C).
    4. David Bardey & Philippe De Donder, 2015. "Welfare Impacts of Genetic Testing in Health Insurance Markets: Will Cross-Subsidies Survive?," Documentos CEDE 17220, Universidad de los Andes, Facultad de Economía, CEDE.

  8. David Bardey & Denis Gromb & David Martimort & Jerome Pouyet, 2016. "Drugs, Showrooms and Financial Products: Competition and Regulation when Sellers Provide Expert Advice," Documentos CEDE 15231, Universidad de los Andes, Facultad de Economía, CEDE.

    Cited by:

    1. Danilo Liberati & Francesco Vercelli, 2019. "As long as the bank gains: expanding the retail distribution activity," Questioni di Economia e Finanza (Occasional Papers) 510, Bank of Italy, Economic Research and International Relations Area.

  9. David Bardey & Daniel Mejia, 2016. "Informality and Optimal Public Policy," Documentos CEDE 14229, Universidad de los Andes, Facultad de Economía, CEDE.

    Cited by:

    1. Andres García-Suaza & Fernando Jaramillo & Marlon Salazar, 2023. "Tax policies, informality, and real wage rigidities," Borradores de Economia 1245, Banco de la Republica de Colombia.
    2. Salazar, M., 2021. "Tax policies, informality, and real wage rigidities," Documentos de trabajo - Alianza EFI 20044, Alianza EFI.
    3. Acosta-Henao, Miguel, 2023. "Law enforcement and the size of the informal sector," Economic Modelling, Elsevier, vol. 126(C).

  10. David Bardey & Helmuth Cremer & Jean-Marie Lozachmeur, 2015. "The Design of Insurance Coverage for Medical Products under Imperfect Competition," CESifo Working Paper Series 5235, CESifo.

    Cited by:

    1. David Bardey & Arturo Harker & Daniela Zuluaga, 2021. "Price cap regulation in the Colombian pharmaceutical market: An impact evaluation," Documentos CEDE 19117, Universidad de los Andes, Facultad de Economía, CEDE.
    2. Cremer, Helmuth & Lozachmeur, Jean-Marie, 2021. "Coinsurance vs. copayments: reimbursement rules for a monopolistic medical product with competitive health insurers," CEPR Discussion Papers 16238, C.E.P.R. Discussion Papers.
    3. Bardey, David & Li, Sanxi & Wu, Yaping, 2015. "Health Care Insurance Payment Policy when the Physician and Patient May Collude," TSE Working Papers 15-572, Toulouse School of Economics (TSE).
    4. Catalina Gutiérrez S. & Nicolás Gómez, 2018. "El sistema de salud colombiano en las próximas décadas: cómo avanzar hacia la sostenibilidad y la calidad en la atención," Cuadernos de Fedesarrollo 16251, Fedesarrollo.
    5. Mak, Henry Y., 2018. "Managing imperfect competition by pay for performance and reference pricing," Journal of Health Economics, Elsevier, vol. 57(C), pages 131-146.
    6. Gilad Sorek & Randolph T. Beard, 2016. "Regulating from the Demand Side: Public Health Insurance with Monopolistically Competitive Providers and Optional Spot Sales," Auburn Economics Working Paper Series auwp2016-06, Department of Economics, Auburn University.

  11. Buitrago, Giancarlo & Bardey, David, 2015. "Voluntary Health Plan Subsidies and Public Expenditure," Documentos CEDE Series 212854, Universidad de Los Andes, Economics Department.

    Cited by:

    1. Bardey, David & Buitrago, Giancarlo, 2016. "Supplementary health insurance in the Colombian managed care system: Adverse or advantageous selection?," TSE Working Papers 16-709, Toulouse School of Economics (TSE).
    2. Cristina Pardo-Garcia & Jose J. Sempere-Monerris, 2018. "Mixed provision of health care services with double coverage," Journal of Economics, Springer, vol. 123(1), pages 49-70, January.

  12. David Bardey & Philippe De Donder & Cesar Mantilla, 2014. "Adverse Selection vs Discrimination Risk with Genetic Testing. An Experimental Approach," CESifo Working Paper Series 5080, CESifo.

    Cited by:

    1. Simeon Schudy & Verena Utikal, 2015. "Does imperfect data privacy stop people from collecting personal health data?," TWI Research Paper Series 98, Thurgauer Wirtschaftsinstitut, Universität Konstanz.
    2. Simeon Schudy & Verena Utikal, 2018. "Does Imperfect Data Privacy Stop People from Collecting Personal Data?," Games, MDPI, vol. 9(1), pages 1-23, March.

  13. David Bardey & Bruno Jullien & Jean-Marie Lozachmeur, 2013. "Health Insurance and Diversity of Treatment: A Policy Mix Perspective," CESifo Working Paper Series 4111, CESifo.

    Cited by:

    1. Puig-Junoy, Jaume & López-Valcárcel, Beatriz González, 2014. "Launch prices for new pharmaceuticals in the heavily regulated and subsidized Spanish market, 1995–2007," Health Policy, Elsevier, vol. 116(2), pages 170-181.

  14. David Bardey & Alejandro Becerra & Pilar Cabrera, 2013. "Análisis económico de la normativa de libre competencia en Colombia," Cuadernos de Fedesarrollo 11561, Fedesarrollo.

    Cited by:

    1. Felipe Núñez Forero, 2017. "Servicios públicos domiciliarios, telecomunicaciones e infraestructura (instituciones, regulación y competencia)," Books, Universidad Externado de Colombia, Facultad de Derecho, number 947, October.

  15. David Bardey & Fermando Jaramillo & Ximena Pena, 2013. "Unemployment insurance in the presence of an informal," Documentos de Trabajo 11014, Universidad del Rosario.

    Cited by:

    1. Romain Duval & Prakash Loungani, 2021. "Designing Labor Market Institutions in Emerging Market and Developing Economies: A Review of Evidence and IMF Policy Advice," Comparative Economic Studies, Palgrave Macmillan;Association for Comparative Economic Studies, vol. 63(1), pages 31-83, March.
    2. Carmen UZLAU & Mariana BALAN & Corina-Maria ENE, 2017. "Labour Market Vulnerabilities In Romania During The Post- Crisis Period," Internal Auditing and Risk Management, Athenaeum University of Bucharest, vol. 46(2), pages 12-27, June.
    3. Iain W. Long & Vito Polito, 2017. "Job Search, Unemployment Protection and Informal Work in Advanced Economies," CESifo Working Paper Series 6763, CESifo.

  16. David Bardey & Fernando Jaramillo & Ximena Peña, 2013. "Unemployment Insurance in the Presence of an Informal Sector," Documentos CEDE 10496, Universidad de los Andes, Facultad de Economía, CEDE.

    Cited by:

    1. Romain Duval & Prakash Loungani, 2021. "Designing Labor Market Institutions in Emerging Market and Developing Economies: A Review of Evidence and IMF Policy Advice," Comparative Economic Studies, Palgrave Macmillan;Association for Comparative Economic Studies, vol. 63(1), pages 31-83, March.
    2. Mantilla, Cesar & Rincón, Ferley, 2022. "Mobility and productivity in a dual labor market: an experiment," OSF Preprints 5as84, Center for Open Science.
    3. Carmen UZLAU & Mariana BALAN & Corina-Maria ENE, 2017. "Labour Market Vulnerabilities In Romania During The Post- Crisis Period," Internal Auditing and Risk Management, Athenaeum University of Bucharest, vol. 46(2), pages 12-27, June.
    4. Iain W. Long & Vito Polito, 2017. "Job Search, Unemployment Protection and Informal Work in Advanced Economies," CESifo Working Paper Series 6763, CESifo.

  17. David Bardey & Marcela Meléndez, 2012. "La economía de los mercados de dos lados: aplicación al análisis de las tarjetas de pago en Colombia," Documentos CEDE 10021, Universidad de los Andes, Facultad de Economía, CEDE.

    Cited by:

    1. Carlos Alberto Arango-Arango & Yanneth Rocío Betancourt-García & Manuela Restrepo-Bernal, 2021. "An Application of the Tourist Test to Colombian Merchants," Borradores de Economia 1176, Banco de la Republica de Colombia.

  18. BARDEY, David & CANTA, Chiara & LOZACHMEUR, Jean-Marie, 2012. "The regulation of health care providers' payments when horizontal and vertical differentiation matter," LIDAM Reprints CORE 2441, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).

    Cited by:

    1. Sorek Gilad, 2016. "Competition and Product Choice in Option Demand Markets," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 16(2), pages 785-805, April.
    2. Ziad Ghandour & Odd Rune Straume, 2022. "Optimal funding coverage in a mixed oligopoly with quality competition and price regulation," Journal of Economics, Springer, vol. 136(3), pages 201-225, August.
    3. Gu, Yiquan & Rasch, Alexander & Wenzel, Tobias, 2020. "Consumer salience and quality provision in (un)regulated public service markets," ZEW Discussion Papers 20-087, ZEW - Leibniz Centre for European Economic Research.
    4. Michel Mougeot & Florence Naegelen, 2018. "Achieving a fair geographical distribution of health-care resources," Post-Print hal-01816851, HAL.
    5. Engin Yilmaz & Albert Vuagnat, 2015. "Tarification à l'activité et réadmission," Économie et Statistique, Programme National Persée, vol. 475(1), pages 71-87.
    6. Michele Bisceglia & Roberto Cellini & Luigi Siciliani & Odd Rune Straume, 2019. "Optimal dynamic volume-based price regulation," NIPE Working Papers 06/2019, NIPE - Universidade do Minho.
    7. Domenico Lisi & Luigi Siciliani & Odd Rune Straume, 2020. "Hospital competition under pay‐for‐performance: Quality, mortality, and readmissions," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 29(2), pages 289-314, April.
    8. Ricardo Gonçalves & Vasco Rodrigues & Hélder Vasconcelos, 2015. "Reference pricing in the presence of pseudo-generics," International Journal of Health Economics and Management, Springer, vol. 15(3), pages 281-305, September.
    9. Gilad Sorek, 2015. "Health Insurance and Competition in Health Care Markets," Auburn Economics Working Paper Series auwp2015-03, Department of Economics, Auburn University.
    10. Mak, Henry Y., 2018. "Managing imperfect competition by pay for performance and reference pricing," Journal of Health Economics, Elsevier, vol. 57(C), pages 131-146.
    11. Hehenkamp, Burkhard & Kaarbøe, Oddvar M., 2020. "Location choice and quality competition in mixed hospital markets," Journal of Economic Behavior & Organization, Elsevier, vol. 177(C), pages 641-660.
    12. Alexander Karpov, 2014. "Patient Mobility, Health Care Quality, Welfare And Regulation," HSE Working papers WP BRP 64/EC/2014, National Research University Higher School of Economics.
    13. Sorek, Gilad, 2016. "Competition and consumer choice in option demand markets," Economics Letters, Elsevier, vol. 146(C), pages 13-16.
    14. Vomhof, Markus, 2016. "Hospital competition with heterogeneous patient groups: Incentives and regulation," Ruhr Economic Papers 624, RWI - Leibniz-Institut für Wirtschaftsforschung, Ruhr-University Bochum, TU Dortmund University, University of Duisburg-Essen.
    15. Calogero Guccio & Domenico Lisi & Giacomo Pignataro, 2016. "Readmission and Hospital Quality under Different Payment Regimes," FinanzArchiv: Public Finance Analysis, Mohr Siebeck, Tübingen, vol. 72(4), pages 453-474, December.

  19. David Bardey & Philippe De Donder, 2012. "Genetic testing with primary prevention and moral hazard," Documentos CEDE 9798, Universidad de los Andes, Facultad de Economía, CEDE.

    Cited by:

    1. Goulão, Catarina & Thibault, Emmanuel, 2013. "Physical Activity and Policy Recommendations: a Social Multiplier Approach," IDEI Working Papers 782, Institut d'Économie Industrielle (IDEI), Toulouse.
    2. Simeon Schudy & Verena Utikal, 2015. "Does imperfect data privacy stop people from collecting personal health data?," TWI Research Paper Series 98, Thurgauer Wirtschaftsinstitut, Universität Konstanz.
    3. Bardey, David & De Donder, Philippe, 2019. "A Welfare Analysis of Genetic Testing in Health Insurance Markets with Adverse Selection and Prevention," TSE Working Papers 19-1035, Toulouse School of Economics (TSE), revised 22 Jan 2024.
    4. Diego C. Nocetti, 2018. "Ambiguity and the value of information revisited," The Geneva Risk and Insurance Review, Palgrave Macmillan;International Association for the Study of Insurance Economics (The Geneva Association), vol. 43(1), pages 25-38, May.
    5. Simeon Schudy & Verena Utikal, 2012. "The Influence of (Im)perfect Data Privacy on the Acquisition of Personal Health Data," TWI Research Paper Series 76, Thurgauer Wirtschaftsinstitut, Universität Konstanz.
    6. Shooshan Danagoulian, 2018. "Policy of prevention: Medical utilization under a wellness plan," Health Economics, John Wiley & Sons, Ltd., vol. 27(11), pages 1843-1858, November.
    7. David Crainich, 2017. "Self-Insurance With Genetic Testing Tools," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 84(1), pages 73-94, March.
    8. Wanda Mimra & Janina Nemitz & Christian Waibel, 2019. "Voluntary pooling of genetic risk: A health insurance experiment," Post-Print hal-02499086, HAL.
    9. Simeon Schudy & Verena Utikal, 2018. "Does Imperfect Data Privacy Stop People from Collecting Personal Data?," Games, MDPI, vol. 9(1), pages 1-23, March.
    10. Filipova-Neumann, Lilia & Hoy, Michael, 2014. "Managing genetic tests, surveillance, and preventive medicine under a public health insurance system," Journal of Health Economics, Elsevier, vol. 34(C), pages 31-41.
    11. Tan, Kar Man & Gründl, Helmut, 2023. "Testing frequency and severity risk under various information regimes and implications in insurance," ICIR Working Paper Series 49/23, Goethe University Frankfurt, International Center for Insurance Regulation (ICIR).
    12. Mimra, Wanda & Nemitz, Janina & Waibel, Christian, 2020. "Voluntary pooling of genetic risk: A health insurance experiment," Journal of Economic Behavior & Organization, Elsevier, vol. 180(C), pages 864-882.
    13. David Bardey & Philippe De Donder & César Mantilla, 2014. "Adverse Selection vs Discrimination Risk with Genetic Testing. An Experimental Approach," Documentos CEDE 12341, Universidad de los Andes, Facultad de Economía, CEDE.
    14. Bardey, David & De Donder, Philippe & Mantilla, César, 2019. "How is the trade-off between adverse selection and discrimination risk affected by genetic testing? Theory and experiment," Journal of Health Economics, Elsevier, vol. 68(C).
    15. Jisang Yu & Nathan P. Hendricks, 2020. "Input Use Decisions with Greater Information on Crop Conditions: Implications for Insurance Moral Hazard and the Environment," American Journal of Agricultural Economics, John Wiley & Sons, vol. 102(3), pages 826-845, May.
    16. Posey, Lisa L. & Thistle, Paul D., 2021. "Genetic testing and genetic discrimination: Public policy when insurance becomes “too expensive”," Journal of Health Economics, Elsevier, vol. 77(C).
    17. Lagerlof, Johan & Schottmüller, Christoph, 2013. "Monopoly Insurance with Endogenous Information," CEPR Discussion Papers 9774, C.E.P.R. Discussion Papers.
    18. Stefan Felder, 2022. "Decision thresholds with genetic testing," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(6), pages 1071-1078, August.
    19. Fernando Antoñanzas & Carmelo A. Juárez-Castelló & Roberto Rodríguez-Ibeas, 2016. "Implementing personalized medicine with asymmetric information on prevalence rates," Health Economics Review, Springer, vol. 6(1), pages 1-8, December.
    20. David Bardey & Philippe de Donder, 2023. "Personalized Medicine and Prevention: Can Cross-Subsidies Survive in the Health Insurance Markets ?," Working Papers hal-04082748, HAL.
    21. Daniel Gallacher & Nigel Stallard & Peter Kimani & Elvan Gökalp & Juergen Branke, 2022. "Development of a model to demonstrate the impact of National Institute of Health and Care Excellence cost‐effectiveness assessment on health utility for targeted medicines," Health Economics, John Wiley & Sons, Ltd., vol. 31(2), pages 417-430, February.
    22. Felix C.H. Gottschalk, 2019. "Why prevent when it does not pay? Prevention when health services are credence goods," Health Economics, John Wiley & Sons, Ltd., vol. 28(5), pages 693-709, May.
    23. David Bardey & Philippe De Donder, 2015. "Welfare Impacts of Genetic Testing in Health Insurance Markets: Will Cross-Subsidies Survive?," Documentos CEDE 17220, Universidad de los Andes, Facultad de Economía, CEDE.
    24. Peter, Richard & Richter, Andreas & Thistle, Paul, 2017. "Endogenous information, adverse selection, and prevention: Implications for genetic testing policy," Journal of Health Economics, Elsevier, vol. 55(C), pages 95-107.
    25. Christine Arentz, 2012. "Auswirkungen von Gentests in der Krankenversicherung," Otto-Wolff-Institut Discussion Paper Series 04/2012, Otto-Wolff-Institut für Wirtschaftsordnung, Köln, Deutschland.

  20. David Bardey & Fernando Jaramillo, 2011. "Unemployment insurance and informality in developing countries," Documentos de Trabajo 9015, Universidad del Rosario.

    Cited by:

    1. Luz Adriana Flórez, 2014. "The Efficiency of the Informal Sector on the Search and Matching Framework," Borradores de Economia 832, Banco de la Republica de Colombia.
    2. Carlos medina & Jairo Núñez & Jorge Andrés Tamayo, 2013. "The Unemployment Subsidy Program in Colombia: An Assessment," Borradores de Economia 750, Banco de la Republica de Colombia.

  21. Bardey, David & Canta, Chiara & Lozachmeur, Jean-Marie, 2010. "Health Care Providers Payments Regulation when Horizontal and Vertical Differentiation Matter," IDEI Working Papers 532, Institut d'Économie Industrielle (IDEI), Toulouse.

    Cited by:

    1. Annika Herr, 2011. "Quality and Welfare in a Mixed Duopoly with Regulated Prices: The Case of a Public and a Private Hospital," German Economic Review, Verein für Socialpolitik, vol. 12(4), pages 422-437, November.
    2. Kairies-Schwarz, Nadja, 2014. "Altruism Heterogeneity and Quality Competition Among Healthcare Providers," Ruhr Economic Papers 507, RWI - Leibniz-Institut für Wirtschaftsforschung, Ruhr-University Bochum, TU Dortmund University, University of Duisburg-Essen.

  22. David Bardey & Jean-Marc Bourgeon, 2010. "Healt care network formation and policyholders'welfare," Documentos de Trabajo 7457, Universidad del Rosario.

    Cited by:

    1. Sorek Gilad, 2016. "Competition and Product Choice in Option Demand Markets," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 16(2), pages 785-805, April.
    2. David Bardey & Giancarlo Buitrago, 2015. "Integración vertical en el sector de la salud colombiano," Documentos CEDE 14069, Universidad de los Andes, Facultad de Economía, CEDE.
    3. Gilad Sorek, 2015. "Health Insurance and Competition in Health Care Markets," Auburn Economics Working Paper Series auwp2015-03, Department of Economics, Auburn University.
    4. Edmond Baranes & David Bardey, 2015. "Competition between health maintenance organizations and nonintegrated health insurance companies in health insurance markets," Health Economics Review, Springer, vol. 5(1), pages 1-9, December.
    5. Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2022. "Paying for pharmaceuticals: uniform pricing versus two-part tariffs," Journal of Health Economics, Elsevier, vol. 83(C).
    6. Sorek, Gilad, 2016. "Competition and consumer choice in option demand markets," Economics Letters, Elsevier, vol. 146(C), pages 13-16.

  23. Helmuth Cremer & David Bardey & Jean-Marie Lozachmeur, 2009. "Competition in two-sided markets with common network externalities," Documentos de Trabajo 5937, Universidad del Rosario.

    Cited by:

    1. David Bardey & Luigi Siciliani, 2021. "Nursing homes' competition and distributional implications when the market is two-sided," Post-Print hal-03340880, HAL.
    2. Damien Besancenot & Karine Lamiraud & Radu Vranceanu, 2023. "A model for dual health care market with congestion differentiation," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 32(2), pages 400-423, April.
    3. Guillaume Roger, 2017. "Two-sided competition with vertical differentiation," Journal of Economics, Springer, vol. 120(3), pages 193-217, April.
    4. BELLEFLAMME, Paul & TOULEMONDE, Eric, 2016. "Who Benefits from Increased Competition Among Sellers on B2C Platforms?," LIDAM Discussion Papers CORE 2016031, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
    5. Annika Herr, 2011. "Quality and Welfare in a Mixed Duopoly with Regulated Prices: The Case of a Public and a Private Hospital," German Economic Review, Verein für Socialpolitik, vol. 12(4), pages 422-437, November.
    6. Guillaume Monchambert, 2023. "Pricing of myopic multi-sided platforms: theory and application to carpooling," Working Papers halshs-03980205, HAL.
    7. Wenqing Wu & Xuan Huang & Yue Li & Chien-Chi Chu, 2018. "Optimal Quality Strategy and Matching Service on Crowdfunding Platforms," Sustainability, MDPI, vol. 10(4), pages 1-17, April.
    8. Wu, Wenqing & Huang, Xuan & Wu, Chia-Huei & Tsai, Sang-Bing, 2022. "Pricing strategy and performance investment decisions in competitive crowdfunding markets," Journal of Business Research, Elsevier, vol. 140(C), pages 491-497.

  24. Bardey, David & Bommier, Antoine & Jullien, Bruno, 2009. "Retail Price Regulation and Innovation: Reference Pricing in the Pharmaceutical Industry," IDEI Working Papers 432, Institut d'Économie Industrielle (IDEI), Toulouse.

    Cited by:

    1. David Bardey & Arturo Harker & Daniela Zuluaga, 2021. "Price cap regulation in the Colombian pharmaceutical market: An impact evaluation," Documentos CEDE 19117, Universidad de los Andes, Facultad de Economía, CEDE.
    2. Paula González & Inés Macho-Stadler & David Pérez-Castrillo, 2015. "Private versus Social Incentives for Pharmaceutical Innovation," Working Papers 15.07, Universidad Pablo de Olavide, Department of Economics.
    3. Levaggi, Rosella, 2014. "Pricing schemes for new drugs: A welfare analysis," Social Science & Medicine, Elsevier, vol. 102(C), pages 69-73.
    4. Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2023. "The price of cost-effectiveness thresholds," Discussion Paper Series in Economics 4/2023, Norwegian School of Economics, Department of Economics.
    5. Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2023. "Taking the competitor’s pill: when combination therapies enter pharmaceutical markets," Discussion Paper Series in Economics 19/2023, Norwegian School of Economics, Department of Economics.
    6. Refoios Camejo, Rodrigo & McGrath, Clare & Herings, Ron, 2011. "A dynamic perspective on pharmaceutical competition, drug development and cost effectiveness," Health Policy, Elsevier, vol. 100(1), pages 18-24, April.
    7. Yanke Dai & Yangfei Xu, 2022. "Cheating under Regulation: Evidence from “Yin-and-Yang” Contracts on Beijing’s Housing Market," Sustainability, MDPI, vol. 14(20), pages 1-29, October.
    8. Kurt R. Brekke & Chiara Canta & Odd Rune Straume, 2015. "Reference pricing with endogenous generic entry," NIPE Working Papers 2/2015, NIPE - Universidade do Minho.
    9. Francesca Barigozzi & Izabela Jelovac, 2019. "Research funding and price negotiation for new drugs," Post-Print halshs-02148462, HAL.
    10. Giorgio Matteucci & Pierfrancesco Reverberi, 2017. "Drug innovation, price controls, and parallel trade," International Journal of Health Economics and Management, Springer, vol. 17(2), pages 159-179, June.
    11. Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2022. "Competing with precision: incentives for developing predictive biomarker tests," NIPE Working Papers 3/2022, NIPE - Universidade do Minho.
    12. David Bardey & Helmuth Cremer & Jean-Marie Lozachmeur, 2015. "The Design of Insurance Coverage for Medical Products under Imperfect Competition," CESifo Working Paper Series 5235, CESifo.
    13. Bruno Jullien & Yassine Lefouili, 2018. "Horizontal mergers and innovation," Post-Print hal-03263838, HAL.
    14. Puig-Junoy, Jaume & López-Valcárcel, Beatriz González, 2014. "Launch prices for new pharmaceuticals in the heavily regulated and subsidized Spanish market, 1995–2007," Health Policy, Elsevier, vol. 116(2), pages 170-181.
    15. Hanna Koskinen & Elina Ahola & Leena Saastamoinen & Hennamari Mikkola & Jaana Martikainen, 2014. "The impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic medication in Finland," Health Economics Review, Springer, vol. 4(1), pages 1-10, December.
    16. Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2023. "The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical markets," Journal of Health Economics, Elsevier, vol. 90(C).
    17. Brekke, Kurt R. & Holmas, Tor Helge & Straume, Odd Rune, 2011. "Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment," Journal of Public Economics, Elsevier, vol. 95(7), pages 624-638.
    18. Dubois, Pierre & de Mouzon, Olivier & Scott Morton, Fiona & Seabright, Paul, 2011. "Market Size and Pharmaceutical Innovation," TSE Working Papers 11-232, Toulouse School of Economics (TSE), revised Mar 2014.
    19. Chen, Xu & Yang, Huan & Wang, Xiaojun, 2019. "Effects of price cap regulation on the pharmaceutical supply chain," Journal of Business Research, Elsevier, vol. 97(C), pages 281-290.
    20. Fernando Antoñanzas & Carmelo Juárez-Castelló & Roberto Rodríguez-Ibeas, 2011. "Innovation, loyalty and generic competition in pharmaceutical markets," SERIEs: Journal of the Spanish Economic Association, Springer;Spanish Economic Association, vol. 2(1), pages 75-95, March.
    21. Le, Son & Sukhatme, Neel U., 2020. "Reaching for mediocrity: Competition and stagnation in pharmaceutical innovation," International Review of Law and Economics, Elsevier, vol. 64(C).
    22. Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2022. "Paying for pharmaceuticals: uniform pricing versus two-part tariffs," Journal of Health Economics, Elsevier, vol. 83(C).
    23. Charitini Stavropoulou & Tommaso Valletti, 2015. "Compulsory licensing and access to drugs," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(1), pages 83-94, January.
    24. Straume, Odd Rune, 2023. "Therapeutic reference pricing and drug innovation incentives," Economics Letters, Elsevier, vol. 222(C).
    25. Hassan Heidari & Arash Refah Kahriz & Yousef Mohammadzadeh, 2019. "Stock market behavior of pharmaceutical industry in Iran and macroeconomic factors," Economic Change and Restructuring, Springer, vol. 52(3), pages 255-277, August.
    26. Rodrigo Refoios Camejo & Clare McGrath & Marisa Miraldo & Frans Rutten, 2013. "The Determinants of Cost-Effectiveness Potential: An Historical Perspective on Lipid-Lowering Therapies," PharmacoEconomics, Springer, vol. 31(5), pages 445-454, May.

  25. David Bardey & Jean-Charles Rochet, 2009. "Competition among health plans: a two-sided market approach," Documentos de Trabajo 5217, Universidad del Rosario.

    Cited by:

    1. Francisco J. Gomes & Laurence J. Kotlikoff & Luis M. Viceira, 2007. "The Excess Burden of Government Indecision," NBER Working Papers 12859, National Bureau of Economic Research, Inc.
    2. Mark J. Tremblay, 2016. "Vertical Relationships within Platform Marketplaces," Games, MDPI, vol. 7(3), pages 1-11, July.
    3. Boone, Jan, 2019. "Health provider networks with private contracts: Is there under-treatment in narrow networks?," Journal of Health Economics, Elsevier, vol. 67(C).
    4. Guillaume Roger, 2017. "Two-sided competition with vertical differentiation," Journal of Economics, Springer, vol. 120(3), pages 193-217, April.
    5. Boone, J. & Schottmuller, C., 2015. "Health Provider Networks, Quality and Costs," Other publications TiSEM 5876be16-fe6d-49b8-9b33-4, Tilburg University, School of Economics and Management.
    6. Jullien, Bruno, 2010. "Two-Sided B2B Platforms," TSE Working Papers 11-223, Toulouse School of Economics (TSE), revised Mar 2011.
    7. David Bardey & Giancarlo Buitrago, 2015. "Integración vertical en el sector de la salud colombiano," Documentos CEDE 14069, Universidad de los Andes, Facultad de Economía, CEDE.
    8. Bardey, David & Cremer, Helmuth & Lozachmeur, Jean-Marie, 2009. "Competition in two-sided markets with common network externalities," TSE Working Papers 09-103, Toulouse School of Economics (TSE), revised Oct 2010.
    9. Rachel Kreier & Bhaswati Sengupta, 2015. "Income, Health, and the Value of Preserving Options," Atlantic Economic Journal, Springer;International Atlantic Economic Society, vol. 43(4), pages 431-448, December.
    10. Boone, Jan & Zwart, Gijsbert, 2011. "Competition leverage: how the demand side affects optimal risk adjustment," CEPR Discussion Papers 8461, C.E.P.R. Discussion Papers.
    11. Philippe Chone & Ching-to Albert Ma, 2007. "Optimal Health Care Contracts under Physician Agency," Boston University - Department of Economics - Working Papers Series WP2007-041, Boston University - Department of Economics, revised Sep 2007.
    12. Edmond Baranes & David Bardey, 2015. "Competition between health maintenance organizations and nonintegrated health insurance companies in health insurance markets," Health Economics Review, Springer, vol. 5(1), pages 1-9, December.
    13. Wang, Xiaolei & He, Fang & Yang, Hai & Oliver Gao, H., 2016. "Pricing strategies for a taxi-hailing platform," Transportation Research Part E: Logistics and Transportation Review, Elsevier, vol. 93(C), pages 212-231.
    14. David Bardey & Marcela Meléndez, 2012. "La economía de los mercados de dos lados: aplicación al análisis de las tarjetas de pago en Colombia," Documentos CEDE 10021, Universidad de los Andes, Facultad de Economía, CEDE.
    15. David Bardey & Jean-Marc Bourgeon, 2010. "Healt care network formation and policyholders'welfare," Documentos de Trabajo 7457, Universidad del Rosario.
    16. Chang, Chih-Wei & Lin, Yan-Shu & Ohta, Hiroshi, 2013. "Optimal location in two-sided markets," Economic Modelling, Elsevier, vol. 35(C), pages 743-750.
    17. Cristina Pardo-Garcia & Jose J. Sempere-Monerris, 2018. "Mixed provision of health care services with double coverage," Journal of Economics, Springer, vol. 123(1), pages 49-70, January.
    18. Bardey David & Cremer Helmuth & Lozachmeur Jean-Marie, 2012. "Doctors' Remuneration Schemes and Hospital Competition in a Two-Sided Market," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 12(1), pages 1-31, November.
    19. Audrey Boilley, 2013. "Duopoly Competition and Regulation in a Two-Sided Health Care Insurance Market with Product Differentiation," Working Papers 2013-02, CRESE.

  26. David Bardey & Samir Kiuhan & Julio César Suárez, 2009. "Seguros de desempleo: revisión de literatura y propuesta para Colombia," Documentos de Trabajo 5739, Universidad del Rosario.

    Cited by:

    1. Linares Sánchez, Jose, 2020. "Efectos de las prestaciones por desempleo del Mecanismo de Protección al Cesante sobre la probabilidad de ocuparse en la formalidad y sobre la calidad de los emparejamientos [Effects of unemploymen," MPRA Paper 106698, University Library of Munich, Germany.
    2. Wang, Cheng & Williamson, Stephen, 1996. "Unemployment insurance with moral hazard in a dynamic economy," Carnegie-Rochester Conference Series on Public Policy, Elsevier, vol. 44(1), pages 1-41, June.

  27. Baranes, E. & Bardey, D., 2004. "Competition in Health Care Markets and Vertical Restraints," Cahiers du CREDEN (CREDEN Working Papers) 04.05.45, CREDEN (Centre de Recherche en Economie et Droit de l'Energie), Faculty of Economics, University of Montpellier 1.

    Cited by:

    1. Kassem HAMMOUD & Jaber ABDALLAH, 2019. "Empirical Analysis On Strategy And Hyper - Competition With Smes," Proceedings of the INTERNATIONAL MANAGEMENT CONFERENCE, Faculty of Management, Academy of Economic Studies, Bucharest, Romania, vol. 13(1), pages 951-960, November.
    2. Martin Gaynor & Robert J Town, 2012. "Competition in Health Care Markets," The Centre for Market and Public Organisation 12/282, The Centre for Market and Public Organisation, University of Bristol, UK.
    3. David Bardey & Giancarlo Buitrago, 2015. "Integración vertical en el sector de la salud colombiano," Documentos CEDE 14069, Universidad de los Andes, Facultad de Economía, CEDE.
    4. Salah M. Diab, 2014. "Using the Competitive Dimensions to Achieve Competitive Advantage A Study on Jordanian Private Hospitals," International Journal of Academic Research in Business and Social Sciences, Human Resource Management Academic Research Society, International Journal of Academic Research in Business and Social Sciences, vol. 4(9), pages 138-150, September.

  28. David BARDEY, 2004. "A paradoxical risk aversion effect on the consumers’ demand for quality," Discussion Papers (REL - Recherches Economiques de Louvain) 2004015, Université catholique de Louvain, Institut de Recherches Economiques et Sociales (IRES).

    Cited by:

    1. Steffen Zimmermann & Philipp Herrmann & Dennis Kundisch & Barrie R. Nault, 2018. "Decomposing the Variance of Consumer Ratings and the Impact on Price and Demand," Information Systems Research, INFORMS, vol. 29(4), pages 984-1002, December.

Articles

  1. Yaping Wu & David Bardey & Yijuan Chen & Sanxi Li, 2021. "Health care insurance policies When the provider and patient may collude," Health Economics, John Wiley & Sons, Ltd., vol. 30(3), pages 525-543, March.

    Cited by:

    1. Elias Carroni & Giuseppe Pignataro & Luigi Siciliani, 2023. "Persuasion in Physician Agency," Discussion Papers 23/01, Department of Economics, University of York.

  2. Bardey, David & Kembou, Samuel & Ventelou, Bruno, 2021. "Physicians’ incentives to adopt personalised medicine: Experimental evidence," Journal of Economic Behavior & Organization, Elsevier, vol. 191(C), pages 686-713.
    See citations under working paper version above.
  3. David Bardey & Denis Gromb & David Martimort & Jérôme Pouyet, 2020. "Controlling Sellers Who Provide Advice: Regulation and Competition," Journal of Industrial Economics, Wiley Blackwell, vol. 68(3), pages 409-444, September.
    See citations under working paper version above.
  4. Bardey, David & De Donder, Philippe & Mantilla, César, 2019. "How is the trade-off between adverse selection and discrimination risk affected by genetic testing? Theory and experiment," Journal of Health Economics, Elsevier, vol. 68(C).
    See citations under working paper version above.
  5. David Bardey & Daniel Mejia, 2019. "Informality and Optimal Public Policy," Economía Journal, The Latin American and Caribbean Economic Association - LACEA, vol. 0(Spring 20), pages 1-19, April.
    See citations under working paper version above.
  6. Bardey, David & Buitrago, Giancarlo, 2017. "Supplemental health insurance in the Colombian managed care system: Adverse or advantageous selection?," Journal of Health Economics, Elsevier, vol. 56(C), pages 317-329.

    Cited by:

    1. Ko, Hansoo, 2020. "Moral hazard effects of supplemental private health insurance in Korea," Social Science & Medicine, Elsevier, vol. 265(C).
    2. María Elvira Guerra-Cújar & Mounu Prem & Paul Rodríguez-Lesmes & Juan Fernando Vargas, 2020. "The Peace Baby Boom: Evidence from Colombia's peace agreement with the FARC," HiCN Working Papers 337, Households in Conflict Network.
    3. Catalina Gutiérrez S. & Nicolás Gómez, 2018. "El sistema de salud colombiano en las próximas décadas: cómo avanzar hacia la sostenibilidad y la calidad en la atención," Cuadernos de Fedesarrollo 16251, Fedesarrollo.
    4. De La Mata, Dolores & Machado, Matilde P. & Olivella, Pau & Valdés, Maria Nieves, 2022. "Asymmetric Information with multiple risks: the case of the Chilean Private Health Insurance Market," UC3M Working papers. Economics 35441, Universidad Carlos III de Madrid. Departamento de Economía.
    5. Guerra-Cújar, María Elvira & Prem, Mounu & Rodríguez-Lesmes, Paul & Vargas, Juan F., 2022. "A Peace Baby Boom? Evidence from Colombia’s Peace Agreement," IAST Working Papers 22-135, Institute for Advanced Study in Toulouse (IAST).
    6. Ketki Sheth, 2021. "Delivering health insurance through informal financial groups: Evidence on moral hazard and adverse selection," Health Economics, John Wiley & Sons, Ltd., vol. 30(9), pages 2185-2199, September.

  7. David Bardey & Giancarlo Buitrago, 2016. "Integración vertical en el sector colombiano de la salud," Revista Desarrollo y Sociedad, Universidad de los Andes,Facultad de Economía, CEDE, vol. 77, August.

    Cited by:

    1. Ligia Alba Melo-Becerra & Luis E. Arango & Oscar Iván Ávila-Montealegre & Jhorland Ayala-García & Leonardo Bonilla-Mejía & Jesús Alonso Botero-García & Carolina Crispin-Fory & Manuela Cardona & Daniel, 2023. "Aspectos financieros y fiscales del sistema de salud en Colombia," Revista ESPE - Ensayos sobre Política Económica, Banco de la Republica de Colombia, issue 106, pages 1-92, October.
    2. Catalina Gutiérrez S. & Nicolás Gómez, 2018. "El sistema de salud colombiano en las próximas décadas: cómo avanzar hacia la sostenibilidad y la calidad en la atención," Cuadernos de Fedesarrollo 16251, Fedesarrollo.

  8. Bardey, David & Cremer, Helmuth & Lozachmeur, Jean-Marie, 2016. "The design of insurance coverage for medical products under imperfect competition," Journal of Public Economics, Elsevier, vol. 137(C), pages 28-37.
    See citations under working paper version above.
  9. Bardey, David & Jullien, Bruno & Lozachmeur, Jean-Marie, 2016. "Health insurance and diversity of treatment," Journal of Health Economics, Elsevier, vol. 47(C), pages 50-63.

    Cited by:

    1. Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2023. "The price of cost-effectiveness thresholds," Discussion Paper Series in Economics 4/2023, Norwegian School of Economics, Department of Economics.
    2. Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2023. "Taking the competitor’s pill: when combination therapies enter pharmaceutical markets," Discussion Paper Series in Economics 19/2023, Norwegian School of Economics, Department of Economics.
    3. Igor Letina & Armin Schmutzler & Regina Seibel, 2021. "Killer Acquisitions and Beyond: Policy Effects on Innovation Strategies," Diskussionsschriften dp2003, Universitaet Bern, Departement Volkswirtschaft.
    4. Cremer, Helmuth & Lozachmeur, Jean-Marie, 2021. "Coinsurance vs. copayments: reimbursement rules for a monopolistic medical product with competitive health insurers," CEPR Discussion Papers 16238, C.E.P.R. Discussion Papers.
    5. Kurt R. Brekke & Chiara Canta & Odd Rune Straume, 2015. "Reference pricing with endogenous generic entry," NIPE Working Papers 2/2015, NIPE - Universidade do Minho.
    6. Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2022. "Competing with precision: incentives for developing predictive biomarker tests," NIPE Working Papers 3/2022, NIPE - Universidade do Minho.
    7. David Bardey & Helmuth Cremer & Jean-Marie Lozachmeur, 2015. "The Design of Insurance Coverage for Medical Products under Imperfect Competition," CESifo Working Paper Series 5235, CESifo.
    8. Unsorg, Maximiliane, 2018. "Reference Pricing Systems on the Pharmaceutical Market," VfS Annual Conference 2018 (Freiburg, Breisgau): Digital Economy 181533, Verein für Socialpolitik / German Economic Association.
    9. Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2023. "The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical markets," Journal of Health Economics, Elsevier, vol. 90(C).
    10. Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2022. "Paying for pharmaceuticals: uniform pricing versus two-part tariffs," Journal of Health Economics, Elsevier, vol. 83(C).
    11. Straume, Odd Rune, 2023. "Therapeutic reference pricing and drug innovation incentives," Economics Letters, Elsevier, vol. 222(C).

  10. David Bardey & Fernando Jaramillo & Ximena Peña, 2015. "Unemployment Insurance in the Presence of an Informal Sector," The World Bank Economic Review, World Bank, vol. 29(suppl_1), pages 126-134.
    See citations under working paper version above.
  11. Edmond Baranes & David Bardey, 2015. "Competition between health maintenance organizations and nonintegrated health insurance companies in health insurance markets," Health Economics Review, Springer, vol. 5(1), pages 1-9, December.

    Cited by:

    1. Nayak, Bishwajit & Bhattacharyya, Som Sekhar & Krishnamoorthy, Bala, 2021. "Explicating the role of emerging technologies and firm capabilities towards attainment of competitive advantage in health insurance service firms," Technological Forecasting and Social Change, Elsevier, vol. 170(C).

  12. David Bardey & Helmuth Cremer & Jean-Marie Lozachmeur, 2014. "Competition in Two-Sided Markets with Common Network Externalities," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 44(4), pages 327-345, June.
    See citations under working paper version above.
  13. Bardey, David & De Donder, Philippe, 2013. "Genetic testing with primary prevention and moral hazard," Journal of Health Economics, Elsevier, vol. 32(5), pages 768-779.
    See citations under working paper version above.
  14. Bardey David & Cremer Helmuth & Lozachmeur Jean-Marie, 2012. "Doctors' Remuneration Schemes and Hospital Competition in a Two-Sided Market," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 12(1), pages 1-31, November.

    Cited by:

    1. David Bardey & Luigi Siciliani, 2021. "Nursing homes' competition and distributional implications when the market is two-sided," Post-Print hal-03340880, HAL.
    2. Indranil Dutta & Mario Pezzino & Yan Song, 2022. "Should developing countries ban dual practice by physicians? Analysis under mixed hospital competition," Health Economics, John Wiley & Sons, Ltd., vol. 31(11), pages 2289-2310, November.
    3. De Donder, Philippe & Bardey, David & Zaporozhets, Vera, 2024. "Economic Incentives to Develop and to Use Diagnostic Tests - A Literature Review," TSE Working Papers 24-1507, Toulouse School of Economics (TSE).

  15. Bardey, David & Canta, Chiara & Lozachmeur, Jean-Marie, 2012. "The regulation of health care providers’ payments when horizontal and vertical differentiation matter," Journal of Health Economics, Elsevier, vol. 31(5), pages 691-704.
    See citations under working paper version above.
  16. Bardey David & Bourgeon Jean-Marc, 2011. "Health Care Network Formation and Policyholders' Welfare," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 11(2), pages 1-20, January.
    See citations under working paper version above.
  17. Bardey, D. & Bommier, A. & Jullien, B., 2010. "Retail price regulation and innovation: Reference pricing in the pharmaceutical industry," Journal of Health Economics, Elsevier, vol. 29(2), pages 303-316, March.
    See citations under working paper version above.
  18. David Bardey & Jean‐Charles Rochet, 2010. "Competition Among Health Plans: A Two‐Sided Market Approach," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 19(2), pages 435-451, June.
    See citations under working paper version above.
  19. David Bardey & Romain Lesur, 2006. "Optimal regulation of health system with induced demand and 'ex post' moral hazard," Annals of Economics and Statistics, GENES, issue 83-84, pages 279-293.

    Cited by:

    1. Jeannette Brosig‐Koch & Burkhard Hehenkamp & Johanna Kokot, 2023. "Who benefits from quality competition in health care? A theory and a laboratory experiment on the relevance of patient characteristics," Health Economics, John Wiley & Sons, Ltd., vol. 32(8), pages 1785-1817, August.
    2. DREZE, Jacques H. & SCHOKKAERT, Erik, 2013. "Arrow's theorem of the deductible: moral hazard and stop-loss in health insurance," LIDAM Reprints CORE 2522, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
    3. Yaping Wu & David Bardey & Yijuan Chen & Sanxi Li, 2021. "Health care insurance policies When the provider and patient may collude," Health Economics, John Wiley & Sons, Ltd., vol. 30(3), pages 525-543, March.
    4. Philippe Batifoulier & Nicolas Da Silva, 2014. "Medical Altruism in Mainstream Health Economics: Theoretical and Political Paradoxes," Review of Social Economy, Taylor & Francis Journals, vol. 72(3), pages 261-279, September.
    5. BARDEY, David & CANTA, Chiara & LOZACHMEUR, Jean-Marie, 2012. "The regulation of health care providers' payments when horizontal and vertical differentiation matter," LIDAM Reprints CORE 2441, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
    6. Galina Besstremyannaya & Sergei Golovan, 2019. "Physician’s altruism in incentive contracts: Medicare’s quality race," CINCH Working Paper Series 1903, Universitaet Duisburg-Essen, Competent in Competition and Health.
    7. Kantarevic, Jasmin & Kralj, Boris, 2015. "Physician Payment Contracts in the Presence of Moral Hazard and Adverse Selection: The Theory and its Application to Ontario," IZA Discussion Papers 9142, Institute of Labor Economics (IZA).
    8. Philippe Batifoulier & Nicolas Da Silva, 2014. "The economic behaviour of doctors: medical altruism without an ethic?," EconomiX Working Papers 2014-9, University of Paris Nanterre, EconomiX.
    9. Philippe Batifoulier, 2014. "De l’aléa moral du patient aux inégalités d’accès aux soins," EconomiX Working Papers 2014-7, University of Paris Nanterre, EconomiX.
    10. David Bardey & Jean-Marc Bourgeon, 2010. "Healt care network formation and policyholders'welfare," Documentos de Trabajo 7457, Universidad del Rosario.
    11. David Bardey & Jean-Charles Rochet, 2009. "Competition among health plans: a two-sided market approach," Documentos de Trabajo 5217, Universidad del Rosario.
    12. Barigozzi, Francesca & Levaggi, Rosella, 2008. "Emotions in physician agency," Health Policy, Elsevier, vol. 88(1), pages 1-14, October.
    13. Philippe Batifoulier, 2014. "De l’aléa moral du patient aux inégalités d’accès aux soins," Working Papers hal-04141361, HAL.
    14. Jihong Ding & Minglai Zhu, 2009. "A theoretical investigation of the reformed public health insurance in urban China," Frontiers of Economics in China, Springer;Higher Education Press, vol. 4(1), pages 1-29, March.

  20. Bardey, David & Lesur, Romain, 2005. "Optimal health insurance contract: Is a deductible useful?," Economics Letters, Elsevier, vol. 87(3), pages 313-317, June.

    Cited by:

    1. DREZE, Jacques H. & SCHOKKAERT, Erik, 2013. "Arrow's theorem of the deductible: moral hazard and stop-loss in health insurance," LIDAM Reprints CORE 2522, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
    2. Plisson, Manuel, 2009. "Assurabilité et développement de l'assurance dépendance," Economics Thesis from University Paris Dauphine, Paris Dauphine University, number 123456789/5064 edited by Lorenzi, Jean-Hervé.
    3. Bardey, David & De Donder, Philippe, 2012. "Genetic testing with primary prevention and moral hazard," IDEI Working Papers 729, Institut d'Économie Industrielle (IDEI), Toulouse.
    4. Justina Klimaviciute & Pierre Pestieau, 2018. "Long-term care social insurance: How to avoid big losses?," International Tax and Public Finance, Springer;International Institute of Public Finance, vol. 25(1), pages 99-139, February.
    5. Franck Bien & Arnold Chassagnon & Manuel Plisson, 2011. "Est-il rationnel de ne pas s'assurer contre la dépendance ?," Revue française d'économie, Presses de Sciences-Po, vol. 0(4), pages 161-199.
    6. John E. Murray, 2011. "Asymmetric Information and Countermeasures in Early Twentieth‐Century American Short‐Term Disability Microinsurance," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 78(1), pages 117-138, March.
    7. Franck Bien & Arnold Chassagnon & Manuel Plisson, 2012. "Est-il rationnel de ne pas s'assurer contre la dépendance ?," PSE - Labex "OSE-Ouvrir la Science Economique" halshs-00754579, HAL.

  21. David Bardey, 2004. "A paradoxical risk aversion effect on the consumers' demand for quality," Recherches économiques de Louvain, De Boeck Université, vol. 70(1), pages 109-115.
    See citations under working paper version above.
  22. David Bardey & Agnès Couffinhal & Michel Grignon, 2003. "Efficacité et risque moral ex post en assurance maladie," Revue Française d'Économie, Programme National Persée, vol. 18(2), pages 165-197.

    Cited by:

    1. Batifoulier, Philippe, 2015. "Aux origines de la privatisation du financement du soin : quand la théorie de l’aléa moral rencontre le capitalisme sanitaire," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, vol. 17.
    2. Roquebert, Q. & Tenand, M., 2016. "Pay less, consume more? Estimating the price elasticity of demand for home care services of the disabled elderly," Health, Econometrics and Data Group (HEDG) Working Papers 16/16, HEDG, c/o Department of Economics, University of York.
    3. Philippe Batifoulier, 2014. "De l’aléa moral du patient aux inégalités d’accès aux soins," EconomiX Working Papers 2014-7, University of Paris Nanterre, EconomiX.
    4. Philippe Batifoulier, 2014. "De l’aléa moral du patient aux inégalités d’accès aux soins," Working Papers hal-04141361, HAL.

  23. David Bardey, 2003. "Gestion des risques longs et comportements de risque moral sur les marchés d'assurance maladie la première inefficacité peut-elle éliminer la seconde ?," Revue d'économie politique, Dalloz, vol. 113(3), pages 323-334.

    Cited by:

    1. Plisson, Manuel, 2009. "Assurabilité et développement de l'assurance dépendance," Economics Thesis from University Paris Dauphine, Paris Dauphine University, number 123456789/5064 edited by Lorenzi, Jean-Hervé.
    2. Mouhamadou Fall & Anne Lavigne, 2006. "Contrats d'assurance multipériodiques et déformation des croyances," Working Papers halshs-00008910, HAL.
    3. Mouhamadou FALL & Anne LAVIGNE, 2006. "Multiperiod Health Insurance Contracts & Bayesian Updating of Beliefs," LEO Working Papers / DR LEO 1263, Orleans Economics Laboratory / Laboratoire d'Economie d'Orleans (LEO), University of Orleans.

  24. David Bardey, 2002. "Demande induite et réglementation de médecins altruistes," Revue économique, Presses de Sciences-Po, vol. 53(3), pages 581-588.

    Cited by:

    1. Philippe Batifoulier & Nicolas da Silva, 2014. "The economic behaviour of doctors: medical altruism without an ethic?," Working Papers hal-04141359, HAL.
    2. Philippe Batifoulier & Nicolas Da Silva, 2014. "The economic behaviour of doctors: medical altruism without an ethic?," EconomiX Working Papers 2014-9, University of Paris Nanterre, EconomiX.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.